News & Analysis on Clinical Trial Services & Contract Research And Development
Responding to surging demand for its flu drug Tamiflu, Roche has announced it is expanding its external contractors to fifteen in nine different countries, as its needs for intermediates and finished product increase.
BioTrove and Blue Sky Biotech announce a collaborative effort to provide a unique service solution, utilising mass spectrometry-based high-throughput screening assays on previously unscreenable drug targets.
Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics, (CFFT) have announced they have entered into a collaboration to develop a novel, oral drug candidate for the treatment of cystic fibrosis (CF).
Laureate Pharma, a full service biopharmaceutical development and protein production company, has been given a new contract by Bradmer Pharmaceuticals to develop and manufacture its novel brain cancer treatment for Phase III clinical studies planned...
According to a new report, the pharmaceutical market grew seven per cent, to $602 billion (€501 billion) in 2005. The report highlighted the emerging markets including China, Korea, Mexico, Russia and Turkey, which experienced double-digit growth,...
Kendle, who has been expanding its reach across the globe, targeting the emerging Asia Pacific and Latin American markets, has announced the acquisition of Latin American-based contract research organisation, International Clinical Research.
An innovative technology derived from plants, which is designed for the production of new pharmaceuticals is to form the basis of a new company that is to focus on (bio)pharma firms involved in the discovery, development, production, and...
Outsourcing-Pharma Focus: Cutting the cost of clinical trials
Patient recruitment consumes more time than any other clinical trial activity, costing the industry millions of dollars. However, recruiting patients on the Internet can slash recruitment times and bring drugs to market faster.
The European Union has approved new alternatives to animal testing of drugs and chemicals, which will not only reduce the number of animals needed for testing, but will also increase the accuracy of the tests, thereby making the products concerned safer.
A new discovery paves the way for new laboratory cancer research after scientists have been able to explain just how a gene variant carried in 15 per cent of the population may increase the risk of developing cancer.